Mattias Mandorfer Selected Research

Portal Hypertension

10/2022	Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease.
10/2022	Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD.
9/2022	Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertension.
8/2022	Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis.
4/2022	HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease.
2/2022	Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression.
1/2022	Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis.
1/2022	Low Serum Cholinesterase Identifies Patients With Worse Outcome and Increased Mortality After TIPS.
1/2022	Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites.
12/2021	Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological response.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mattias Mandorfer Research Topics

Disease

47	Fibrosis (Cirrhosis) 12/2022 - 05/2013
35	Liver Diseases (Liver Disease) 11/2022 - 01/2015
35	Portal Hypertension 10/2022 - 05/2013
17	Ascites 07/2022 - 01/2014
15	Hemorrhage 12/2022 - 12/2017
15	Liver Cirrhosis (Hepatic Cirrhosis) 11/2022 - 01/2013
13	Infections 02/2022 - 01/2013
12	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 01/2017
11	End Stage Liver Disease 10/2021 - 01/2017
10	Hepatitis C 10/2022 - 03/2015
7	Inflammation (Inflammations) 01/2022 - 01/2018
7	Chronic Hepatitis C 01/2021 - 01/2013
6	Varicose Veins (Varicose Vein) 04/2022 - 01/2018
6	Thrombosis (Thrombus) 01/2022 - 07/2018
5	Non-alcoholic Fatty Liver Disease 08/2022 - 01/2018
5	Acute-On-Chronic Liver Failure 01/2022 - 10/2017
5	Disease Progression 01/2022 - 09/2019
5	Hepatic Encephalopathy 02/2021 - 01/2018
4	COVID-19 12/2022 - 01/2021
4	Coinfection 11/2021 - 11/2013
4	Fatty Liver 01/2020 - 01/2018
3	Cholestasis 12/2022 - 02/2015
3	Anemia 12/2022 - 01/2014
3	HIV Infections (HIV Infection) 01/2016 - 05/2014
2	Liver Failure 12/2022 - 01/2020
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 08/2022 - 01/2021
2	Liver Neoplasms (Liver Cancer) 04/2022 - 01/2022
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022 - 01/2022
2	Viremia 12/2021 - 01/2020
2	Neoplasms (Cancer) 01/2021 - 01/2018
2	Sarcopenia 11/2020 - 08/2020
2	Erectile Dysfunction 01/2020 - 01/2018
2	Hypertension (High Blood Pressure) 09/2019 - 01/2018
2	Diabetes Mellitus 09/2019 - 01/2016
2	Alcoholism (Alcohol Abuse) 01/2018 - 03/2015
2	Acute Kidney Injury (Acute Renal Failure) 09/2017 - 11/2015
2	Fatigue 07/2016 - 01/2014
2	Peritonitis 01/2016 - 01/2014
2	Insulin Resistance 01/2016 - 03/2015

Drug/Important Bio-Agent (IBA)

13	InterferonsIBA 04/2022 - 11/2013
13	4-(3-chlorophenylsulfanyl)piperidineIBA 02/2022 - 02/2015
10	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2014
9	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2013
9	AlbuminsIBA 04/2022 - 01/2018
8	von Willebrand FactorIBA 08/2022 - 01/2020
8	Antiviral Agents (Antivirals)IBA 01/2022 - 11/2013
7	C-Reactive ProteinIBA 01/2022 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 11/2022 - 03/2015
5	gadolinium ethoxybenzyl DTPA FDA Link 10/2022 - 01/2017
5	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 11/2013
4	Interleukin-6 (Interleukin 6)IBA 12/2021 - 05/2013
4	SodiumIBA 01/2021 - 09/2015
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2015
4	CreatinineIBA 01/2021 - 11/2015
3	BilirubinIBA 12/2022 - 12/2019
3	Carvedilol (Coreg)FDA LinkGeneric 07/2022 - 01/2017
3	Propranolol (Inderal)FDA LinkGeneric 07/2022 - 10/2018
3	AnticoagulantsIBA 05/2022 - 07/2018
3	Transaminases (Aminotransferases)IBA 01/2022 - 02/2015
3	ReninIBA 12/2021 - 01/2017
3	LipidsIBA 09/2019 - 01/2017
3	Alanine Transaminase (SGPT)IBA 01/2019 - 01/2015
3	Polytetrafluoroethylene (Teflon)FDA Link 01/2018 - 12/2017
3	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 06/2016 - 05/2014
2	TransferasesIBA 12/2022 - 01/2019
2	Complement C3 (C3 Complement)IBA 11/2022 - 01/2014
2	CollagenIBA 11/2022 - 08/2022
2	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2022 - 01/2020
2	ProcalcitoninIBA 01/2022 - 01/2021
2	Thrombin FDA Link 01/2022 - 01/2022
2	fibrin fragment D (D-dimer)IBA 01/2022 - 12/2021
2	AntigensIBA 12/2021 - 05/2020
2	AldosteroneIBA 12/2021 - 10/2021
2	Hormones (Hormone)IBA 10/2021 - 02/2019
2	nasIBA 08/2021 - 01/2021
2	Immunoglobulin M (IgM)IBA 02/2021 - 01/2021
2	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 10/2020
2	AntibodiesIBA 01/2021 - 05/2013
2	Immunoglobulin G (IgG)IBA 01/2021 - 05/2013
2	Vitamin A (Retinol)FDA LinkGeneric 12/2020 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 09/2020 - 01/2020
2	Triglycerides (Triacylglycerol)IBA 01/2020 - 09/2019
2	Factor VIII (Coagulation Factor VIII)IBA 01/2020 - 01/2020
2	CholesterolIBA 01/2020 - 09/2019
2	Testosterone (Sustanon)FDA Link 02/2019 - 01/2018
2	Phospholipases (Phospholipase)IBA 01/2019 - 03/2015
2	MetalsIBA 01/2018 - 12/2017
2	DiureticsIBA 01/2018 - 01/2018
2	Adrenergic Agents (Adrenergic Drugs)IBA 10/2017 - 01/2017
2	SofosbuvirIBA 04/2016 - 10/2015
2	daclatasvirIBA 04/2016 - 10/2015
2	hydroxide ionIBA 03/2015 - 01/2013

Therapy/Procedure

27	Therapeutics 05/2022 - 01/2013
12	Transjugular Intrahepatic Portasystemic Shunt 12/2022 - 09/2017
11	Liver Transplantation 12/2021 - 10/2015
7	Surgical Portasystemic Shunt (Portosystemic Shunt) 12/2022 - 12/2017
4	Stents 08/2022 - 12/2017
4	Ligation 01/2022 - 12/2017
3	Contraindications 12/2022 - 05/2014
2	Art Therapy 01/2019 - 01/2016